Rating History for Puma Biotechnology (PBYI) by Citi
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/28/2021 | Yigal Nochomovitz | Upgrade | Buy (Neutral) |
11.00 (N/A) |
6.82 (6.81) |
-0.15% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/28/2021 | Yigal Nochomovitz | Upgrade | Buy (Neutral) |
11.00 (N/A) |
6.82 (6.81) |
-0.15% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||